Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2013

Open Access 01-10-2013 | Research article

α5β1 integrin induces the expression of noncartilaginous procollagen gene expression in articular chondrocytes cultured in monolayers

Authors: Nobuho Tanaka, Yasuko Ikeda, Tetsuo Yamaguchi, Hiroshi Furukawa, Hiroyuki Mitomi, Takumi Nakagawa, Shigeto Tohma, Naoshi Fukui

Published in: Arthritis Research & Therapy | Issue 5/2013

Login to get access

Abstract

Introduction

Articular chondrocytes undergo an obvious phenotypic change when cultured in monolayers. During this change, or dedifferentiation, the expression of type I and type III procollagen is induced where normal chondrocytes express little type I and type III procollagen. In this study, we attempted to determine the mechanism(s) for the induction of such procollagen expression in dedifferentiating chondrocytes.

Methods

All experiments were performed using primary-cultured human articular chondrocytes under approval of institutional review boards. Integrin(s) responsible for the induction of type I and type III procollagen expression were specified by RNAi experiments. The signal pathway(s) involved in the induction were determined by specific inhibitors and RNAi experiments. Adenovirus-mediated experiments were performed to identify a small GTPase regulating the activity of integrins in dedifferentiating chondrocytes. The effect of inhibition of integrins on dedifferentiation was investigated by experiments using echistatin, a potent disintegrin. The effect of echistatin was investigated first with monolayer-cultured chondrocytes, and then with pellet-cultured chondrocytes.

Results

In dedifferentiating chondrocytes, α5β1 integrin was found to be involved in the induction of type I and type III procollagen expression. The induction was known to be mediated by v-akt murine thymoma viral oncogene homolog (AKT) signaling. Among the three AKT isoforms, AKT1 seemed to be most involved in the signaling. Elated RAS viral (r-ras) oncogene homolog (RRAS) was considered to regulate the progression of dedifferentiation by modulating the affinity and avidity of α5β1 integrin to ligands. Echistatin inhibited dedifferentiation of monolayer-cultured chondrocytes. Furthermore, the matrix formed by pellet-cultured chondrocytes more closely resembled that of normal cartilage compared with the controls.

Conclusions

The result of this study has shown, for the first time, that α5β1 integrin may be responsible for the induction of non-cartilaginous collagen expression in chondrocytes undergoing dedifferentiation. Again, this study has shown that the inhibition of ligand ligation to integrins may be an effective strategy to inhibit phenotypic change of cultured chondrocytes, and to improve the quality of matrix synthesized by primary cultured chondrocytes.
Appendix
Available only for authorised users
Literature
1.
go back to reference von der Mark K, Gauss V, von der Mark H, Muller P: Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977, 267: 531-532. 10.1038/267531a0.CrossRefPubMed von der Mark K, Gauss V, von der Mark H, Muller P: Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977, 267: 531-532. 10.1038/267531a0.CrossRefPubMed
2.
go back to reference Benya PD, Padilla SR, Nimni ME: Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 1978, 15: 1313-1321. 10.1016/0092-8674(78)90056-9.CrossRefPubMed Benya PD, Padilla SR, Nimni ME: Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 1978, 15: 1313-1321. 10.1016/0092-8674(78)90056-9.CrossRefPubMed
3.
go back to reference Hayes AJ, Hall A, Brown L, Tubo R, Caterson B: Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem. 2007, 55: 853-866. 10.1369/jhc.7A7210.2007.CrossRefPubMed Hayes AJ, Hall A, Brown L, Tubo R, Caterson B: Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem. 2007, 55: 853-866. 10.1369/jhc.7A7210.2007.CrossRefPubMed
5.
go back to reference Lewis PB, McCarty LP, Kang RW, Cole BJ: Basic science and treatment options for articular cartilage injuries. J Orthop Sports Phys Ther. 2006, 36: 717-727. 10.2519/jospt.2006.2175.CrossRefPubMed Lewis PB, McCarty LP, Kang RW, Cole BJ: Basic science and treatment options for articular cartilage injuries. J Orthop Sports Phys Ther. 2006, 36: 717-727. 10.2519/jospt.2006.2175.CrossRefPubMed
6.
go back to reference Fukui N, Ikeda Y, Tanaka N, Wake M, Yamaguchi T, Mitomi H, Ishida S, Furukawa H, Hamada Y, Miyamoto Y, Sawabe M, Tashiro T, Katsuragawa Y, Tohma S: αvβ5 integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes. Arthritis Rheum. 2011, 63: 1938-1949. 10.1002/art.30351.CrossRefPubMed Fukui N, Ikeda Y, Tanaka N, Wake M, Yamaguchi T, Mitomi H, Ishida S, Furukawa H, Hamada Y, Miyamoto Y, Sawabe M, Tashiro T, Katsuragawa Y, Tohma S: αvβ5 integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes. Arthritis Rheum. 2011, 63: 1938-1949. 10.1002/art.30351.CrossRefPubMed
7.
go back to reference Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T: Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem. 2006, 281: 27229-27241. 10.1074/jbc.M603385200.CrossRefPubMed Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T: Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem. 2006, 281: 27229-27241. 10.1074/jbc.M603385200.CrossRefPubMed
8.
go back to reference Loeser RF, Wallin R: Cell adhesion to matrix Gla protein and its inhibition by an Arg-Gly-Asp-containing peptide. J Biol Chem. 1992, 267: 9459-9462.PubMed Loeser RF, Wallin R: Cell adhesion to matrix Gla protein and its inhibition by an Arg-Gly-Asp-containing peptide. J Biol Chem. 1992, 267: 9459-9462.PubMed
9.
go back to reference Bonaventure J, Kadhom N, Cohen-Solal L, Ng KH, Bourguignon J, Lasselin C, Freisinger P: Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res. 1994, 212: 97-104. 10.1006/excr.1994.1123.CrossRefPubMed Bonaventure J, Kadhom N, Cohen-Solal L, Ng KH, Bourguignon J, Lasselin C, Freisinger P: Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res. 1994, 212: 97-104. 10.1006/excr.1994.1123.CrossRefPubMed
10.
go back to reference Fukui N, Ikeda Y, Ohnuki T, Tanaka N, Hikita A, Mitomi H, Mori T, Juji T, Katsuragawa Y, Yamamoto S, Sawabe M, Yamane S, Suzuki R, Sandell LJ, Ochi T: Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection. Arthritis Rheum. 2008, 58: 154-163. 10.1002/art.23175.CrossRefPubMed Fukui N, Ikeda Y, Ohnuki T, Tanaka N, Hikita A, Mitomi H, Mori T, Juji T, Katsuragawa Y, Yamamoto S, Sawabe M, Yamane S, Suzuki R, Sandell LJ, Ochi T: Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection. Arthritis Rheum. 2008, 58: 154-163. 10.1002/art.23175.CrossRefPubMed
11.
go back to reference Stewart MC, Saunders KM, Burton-Wurster N, Macleod JN: Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res. 2000, 15: 166-174. 10.1359/jbmr.2000.15.1.166.CrossRefPubMed Stewart MC, Saunders KM, Burton-Wurster N, Macleod JN: Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res. 2000, 15: 166-174. 10.1359/jbmr.2000.15.1.166.CrossRefPubMed
12.
go back to reference Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992, 69: 11-25. 10.1016/0092-8674(92)90115-S.CrossRefPubMed Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992, 69: 11-25. 10.1016/0092-8674(92)90115-S.CrossRefPubMed
13.
go back to reference Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell. 2002, 110: 673-687. 10.1016/S0092-8674(02)00971-6.CrossRefPubMed Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell. 2002, 110: 673-687. 10.1016/S0092-8674(02)00971-6.CrossRefPubMed
14.
go back to reference Loeser RF: Integrins and cell signaling in chondrocytes. Biorheology. 2002, 39: 119-124.PubMed Loeser RF: Integrins and cell signaling in chondrocytes. Biorheology. 2002, 39: 119-124.PubMed
15.
go back to reference Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH: Ras GTPases: integrins’ friends or foes?. Nat Rev Mol Cell Biol. 2003, 4: 767-776. 10.1038/nrm1229.CrossRefPubMed Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH: Ras GTPases: integrins’ friends or foes?. Nat Rev Mol Cell Biol. 2003, 4: 767-776. 10.1038/nrm1229.CrossRefPubMed
16.
go back to reference Pula G, Poole AW: Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1. Platelets. 2008, 19: 199-210. 10.1080/09537100701777303.CrossRefPubMed Pula G, Poole AW: Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1. Platelets. 2008, 19: 199-210. 10.1080/09537100701777303.CrossRefPubMed
17.
go back to reference Bolomini-Vittori M, Montresor A, Giagulli C, Staunton D, Rossi B, Martinello M, Constantin G, Laudanna C: Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol. 2009, 10: 185-194. 10.1038/ni.1691.CrossRefPubMed Bolomini-Vittori M, Montresor A, Giagulli C, Staunton D, Rossi B, Martinello M, Constantin G, Laudanna C: Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol. 2009, 10: 185-194. 10.1038/ni.1691.CrossRefPubMed
18.
go back to reference Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF: Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem. 1993, 268: 1058-1065.PubMed Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF: Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem. 1993, 268: 1058-1065.PubMed
19.
go back to reference Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L: Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Cancer Res. 2001, 61: 2232-2238.PubMed Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L: Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Cancer Res. 2001, 61: 2232-2238.PubMed
20.
go back to reference Chiang H, Jiang CC: Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc. 2009, 108: 87-101. 10.1016/S0929-6646(09)60039-5.CrossRefPubMed Chiang H, Jiang CC: Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc. 2009, 108: 87-101. 10.1016/S0929-6646(09)60039-5.CrossRefPubMed
21.
go back to reference Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R: Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am. 2003, 85-A: 185-192.PubMed Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R: Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am. 2003, 85-A: 185-192.PubMed
22.
go back to reference Ishikawa M, Hiraiwa Y, Kubota D, Tsushima M, Watanabe T, Murakami S, Ouchi S, Ajito K: Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility. Bioorg Med Chem. 2006, 14: 2131-2150. 10.1016/j.bmc.2005.10.055.CrossRefPubMed Ishikawa M, Hiraiwa Y, Kubota D, Tsushima M, Watanabe T, Murakami S, Ouchi S, Ajito K: Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility. Bioorg Med Chem. 2006, 14: 2131-2150. 10.1016/j.bmc.2005.10.055.CrossRefPubMed
23.
go back to reference Kubota D, Ishikawa M, Yamamoto M, Murakami S, Hachisu M, Katano K, Ajito K: Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity. Bioorg Med Chem. 2006, 14: 2089-2108. 10.1016/j.bmc.2005.10.060.CrossRefPubMed Kubota D, Ishikawa M, Yamamoto M, Murakami S, Hachisu M, Katano K, Ajito K: Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity. Bioorg Med Chem. 2006, 14: 2089-2108. 10.1016/j.bmc.2005.10.060.CrossRefPubMed
24.
go back to reference Wright MO, Nishida K, Bavington C, Godolphin JL, Dunne E, Walmsley S, Jobanputra P, Nuki G, Salter DM: Hyperpolarisation of cultured human chondrocytes following cyclical pressure-induced strain: evidence of a role for alpha 5 beta 1 integrin as a chondrocyte mechanoreceptor. J Orthop Res. 1997, 15: 742-747. 10.1002/jor.1100150517.CrossRefPubMed Wright MO, Nishida K, Bavington C, Godolphin JL, Dunne E, Walmsley S, Jobanputra P, Nuki G, Salter DM: Hyperpolarisation of cultured human chondrocytes following cyclical pressure-induced strain: evidence of a role for alpha 5 beta 1 integrin as a chondrocyte mechanoreceptor. J Orthop Res. 1997, 15: 742-747. 10.1002/jor.1100150517.CrossRefPubMed
25.
go back to reference Enomoto-Iwamoto M, Iwamoto M, Nakashima K, Mukudai Y, Boettiger D, Pacifici M, Kurisu K, Suzuki F: Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes. J Bone Miner Res. 1997, 12: 1124-1132. 10.1359/jbmr.1997.12.7.1124.CrossRefPubMed Enomoto-Iwamoto M, Iwamoto M, Nakashima K, Mukudai Y, Boettiger D, Pacifici M, Kurisu K, Suzuki F: Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes. J Bone Miner Res. 1997, 12: 1124-1132. 10.1359/jbmr.1997.12.7.1124.CrossRefPubMed
26.
go back to reference Pulai JI, Del Carlo M, Loeser F: The alpha5beta1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum. 2002, 46: 1528-1535. 10.1002/art.10334.CrossRefPubMed Pulai JI, Del Carlo M, Loeser F: The alpha5beta1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum. 2002, 46: 1528-1535. 10.1002/art.10334.CrossRefPubMed
27.
go back to reference Forsyth CB, Pulai J, Loeser RF: Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum. 2002, 46: 2368-2376. 10.1002/art.10502.CrossRefPubMed Forsyth CB, Pulai J, Loeser RF: Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum. 2002, 46: 2368-2376. 10.1002/art.10502.CrossRefPubMed
28.
go back to reference Loeser RF, Forsyth CB, Samarel AM, Im HJ: Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem. 2003, 278: 24577-24585. 10.1074/jbc.M304530200.PubMedCentralCrossRefPubMed Loeser RF, Forsyth CB, Samarel AM, Im HJ: Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem. 2003, 278: 24577-24585. 10.1074/jbc.M304530200.PubMedCentralCrossRefPubMed
29.
go back to reference Del Carlo M, Schwartz D, Erickson EA, Loeser RF: Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic Biol Med. 2007, 42: 1350-1358. 10.1016/j.freeradbiomed.2007.01.035.PubMedCentralCrossRefPubMed Del Carlo M, Schwartz D, Erickson EA, Loeser RF: Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic Biol Med. 2007, 42: 1350-1358. 10.1016/j.freeradbiomed.2007.01.035.PubMedCentralCrossRefPubMed
30.
go back to reference David-Raoudi M, Tranchepain F, Deschrevel B, Vincent JC, Bogdanowicz P, Boumediene K, Pujol JP: Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen. 2008, 16: 274-287. 10.1111/j.1524-475X.2007.00342.x.CrossRefPubMed David-Raoudi M, Tranchepain F, Deschrevel B, Vincent JC, Bogdanowicz P, Boumediene K, Pujol JP: Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen. 2008, 16: 274-287. 10.1111/j.1524-475X.2007.00342.x.CrossRefPubMed
31.
go back to reference Bujor AM, Pannu J, Bu S, Smith EA, Muise-Helmericks RC, Trojanowska M: Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol. 2008, 128: 1906-1914. 10.1038/jid.2008.39.CrossRefPubMed Bujor AM, Pannu J, Bu S, Smith EA, Muise-Helmericks RC, Trojanowska M: Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol. 2008, 128: 1906-1914. 10.1038/jid.2008.39.CrossRefPubMed
32.
go back to reference Xia H, Diebold D, Nho R, Perlman D, Kleidon J, Kahm J, Avdulov S, Peterson M, Nerva J, Bitterman P, Henke C: Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med. 2008, 205: 1659-1672. 10.1084/jem.20080001.PubMedCentralCrossRefPubMed Xia H, Diebold D, Nho R, Perlman D, Kleidon J, Kahm J, Avdulov S, Peterson M, Nerva J, Bitterman P, Henke C: Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med. 2008, 205: 1659-1672. 10.1084/jem.20080001.PubMedCentralCrossRefPubMed
33.
go back to reference Adam M, Deyl Z: Altered expression of collagen phenotype in osteoarthrosis. Clin Chim Acta. 1983, 133: 25-32. 10.1016/0009-8981(83)90017-7.CrossRefPubMed Adam M, Deyl Z: Altered expression of collagen phenotype in osteoarthrosis. Clin Chim Acta. 1983, 133: 25-32. 10.1016/0009-8981(83)90017-7.CrossRefPubMed
34.
go back to reference Aigner T, Bertling W, Stoss H, Weseloh G, von der Mark K: Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest. 1993, 91: 829-837. 10.1172/JCI116303.PubMedCentralCrossRefPubMed Aigner T, Bertling W, Stoss H, Weseloh G, von der Mark K: Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest. 1993, 91: 829-837. 10.1172/JCI116303.PubMedCentralCrossRefPubMed
35.
go back to reference Miller DR, Mankin HJ, Shoji H, D’Ambrosia RD: Identification of fibronectin in preparations of osteoarthritic human cartilage. Connect Tissue Res. 1984, 12: 267-275. 10.3109/03008208409013689.CrossRefPubMed Miller DR, Mankin HJ, Shoji H, D’Ambrosia RD: Identification of fibronectin in preparations of osteoarthritic human cartilage. Connect Tissue Res. 1984, 12: 267-275. 10.3109/03008208409013689.CrossRefPubMed
36.
go back to reference Wang H, Kandel RA: Chondrocytes attach to hyaline or calcified cartilage and bone. Osteoarthritis Cartilage. 2004, 12: 56-64. 10.1016/j.joca.2003.08.007.CrossRefPubMed Wang H, Kandel RA: Chondrocytes attach to hyaline or calcified cartilage and bone. Osteoarthritis Cartilage. 2004, 12: 56-64. 10.1016/j.joca.2003.08.007.CrossRefPubMed
37.
go back to reference Kurtis MS, Schmidt TA, Bugbee WD, Loeser RF, Sah RL: Integrin-mediated adhesion of human articular chondrocytes to cartilage. Arthritis Rheum. 2003, 48: 110-118. 10.1002/art.10704.CrossRefPubMed Kurtis MS, Schmidt TA, Bugbee WD, Loeser RF, Sah RL: Integrin-mediated adhesion of human articular chondrocytes to cartilage. Arthritis Rheum. 2003, 48: 110-118. 10.1002/art.10704.CrossRefPubMed
Metadata
Title
α5β1 integrin induces the expression of noncartilaginous procollagen gene expression in articular chondrocytes cultured in monolayers
Authors
Nobuho Tanaka
Yasuko Ikeda
Tetsuo Yamaguchi
Hiroshi Furukawa
Hiroyuki Mitomi
Takumi Nakagawa
Shigeto Tohma
Naoshi Fukui
Publication date
01-10-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4307

Other articles of this Issue 5/2013

Arthritis Research & Therapy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine